Follow the entities shaping the evidence.

…ne (5-ASA, 5-aminosalicylic acid), used safely in patients with ulcerative colitis, may reduce CRC risk in LS by decreasing microsatellite instabi…

…ational TB budgets, respectively.Conclusions Compared with SOC, mSTR is a more cost-effective treatment option for MDR/RR-TB, which …

…ngoing; updated efficacy outcomes will be presented.Conclusions IDP-023 off-the-shelf allogeneic g-NK-cell therapy alone or in combinat…

…ed favorable, with no new safety signals identified.Conclusions Ivonescimab plus chemotherapy demonstrated a clinically meaningful and stat…

…racers, enabling repeat imaging sessions. The 2 mg mass dose of GEH200520 was selected for Part B of both studies, where GE-269-001 will …

…nt with advanced NSCLC, acquired before and after initiation of Pembrolizumab. Post-ICI treatment, [18F]F-AraG uptake increased across multip…

… levels of Bacteroides and Desulfovibrionaceae, suggesting that BJIKT created a favorable microbial environment for antitumor immunit…

…tratumoral clustering of proliferating CD8+ T cells.Conclusions MDX2004 is a novel multispecific immune rejuvenator that induces robust…

…ICB) has revolutionized treatment for cancers like melanoma and non-small cell lung cancer by reactivating antitumor T cells. However, its impact in ovari…

… patients. High-risk patients exhibited enhanced sensitivity to dasatinib, docetaxel, erlotinib, and gefitinib ( figure 1).Conclusions Th…

…CC), with only 30% achieving complete pathological responses to immunotherapy. While transcriptomic profiling has identified HCC subgroups li…

…in-directed CAR T cells for specific and effective targeting of glioblastoma. Sci Transl Med. 2020 Mar 4;12(533)Ethics Approval The trial ( …